PhD Position in Multi-Modal AI: Become part of the Mac4Me Doctoral Network, a pan-European training program focused on developing multi-modal AI to define macrophage and immune targets for improved anticancer immunotherapy. The position is funded by the European Union’s Horizon Europe MSCA Doctoral Network programme, offering a unique opportunity to delve into the emerging field of tumour cell-immune host interactions and identify new immunotherapy targets.
Fully-Funded PhD Researcher Position in Multi-Modal AI for Identifying New Immune Targets
Designation:
PhD Candidate
| Property | Details |
|---|---|
| Employer | Oslo universitetssykehus HF |
| Town/City | Oslo |
| Positions | 1 |
| Full-time/Part-time | Full-time |
| Employment Type | Contract |
| Percentage of Full-time | 100 |
| Start Date | 01.12.2024 |
| End Date | 30.11.2027 |
| Webcruiter ID | 4874147616 |
Research Area:
The research focuses on developing multi-modal AI to define macrophage and immune targets for improved anticancer immunotherapy, using animal-free organ-on-chip systems to recapitulate early liver, bone, and brain metastasis during cancer development across the lifespan.
Location:
Oslo, Norway
Eligibility/Qualification:
- MSc degree in computer science, biostatistics, bioinformatics, biomathematics, or a relevant field
- Less than 4 years since the completion of the first MSc degree
- Good English skills and a certificate to prove those skills
- Transnational mobility: Not having resided or carried out the main activity in Norway for more than 12 months in the 3 years immediately prior to recruitment
Job Description:
The successful candidate will join the research group of Prof. Tero Aittokallio, specializing in computational approaches that integrate multi-omics genomic and molecular profiling data. Key objectives include the integration of spatial transcriptomics and single-cell RNA-sequencing data, identification of tumor cell-macrophage interactions in relation to clinical data, and the application of multi-modal AI algorithms to define new targets for improved immunotherapy.
How to Apply:
Interested candidates can apply through the official website and must ensure they meet all eligibility criteria and provide the necessary documentation and certifications as specified.
Last Date for Apply:
11.11.2024
